S. Korea Attracts Local Subsidiary Of Italian Drug Maker Bracco
This article was originally published in PharmAsia News
A South Korean subsidiary of Italy's Bracco Imaging launched operations in the country to provide medical-contrast media. As South Korea's first Italian pharmaceutical firm, Bracco Korea plans to compete with other foreign rivals, including Bayer Schering Pharma and GE Healthcare. Until Bracco's decision to set up shop in South Korea, its products had been marketed by Ilsung Pharmaceutical, a local drug maker. (Click here for more
You may also be interested in...
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer's COVID-19 vaccine in 2021 and beyond.
How UK and EU device regulations will differ in 2021, UK approved bodies and Northern Ireland's unfettered access to the UK market were key themes at the ABHI’s annual regulatory conference.
Regulatory pressure to fully approve the first COVID-19 vaccine in China is mounting as top officials tour an inspection agency and two leading manufacturers.